Djurdja Djordjevic

Dr. Djurdja Djordjevic, early-career member of the NMD4C

Early-Career member

Neuromuscular Fellow, The Hospital for Sick Children


Research Interests: Utility of investigations and treatments in neuromuscular disorders, ethical considerations in neurology, and patient experience in the SMA population

LinkedIn profile

Biography

Djurdja completed her pediatric neurology residency followed by a neuromuscular fellowship in Toronto, Ontario at the Hospital for Sick Children in June 2023. She has been running an outpatient neurology clinic and a pediatric EMG clinic in Vancouver, BC since then. She has recently joined the neuromuscular team at BC Children’s Hospital. Her academic and research interests include exploration of biopsychosocial factors and social determinants of health in the treatment of patients with neuromuscular conditions.


Recent Publications

Xiao, L, Djordjevic, D, Kang, S, Gonorazky, H, Chiang, J, Ambreen, M et al.. Disease-modifying therapies for spinal muscular atrophy: Family experience, ethical considerations, and the role of social determinants of health. J Neuromuscul Dis. 2025. 22143602251375561 PMID:40900034

Sagath, L, Kiiski, K, Naidu, K, Patel, K, Jonson, PH, Laarne, M et al.. Structural variation in nebulin and its impact on phenotype and inheritance: establishing a dominant distal phenotype caused by large deletions. Eur J Hum Genet. 2025.33 (9)1153-1162 PMID:40517164

Sagath, L, Kiiski, K, Naidu, K, Patel, K, Jonson, PH, Laarne, M et al.. Structural variation in nebulin and its implications on phenotype and inheritance: establishing a dominant distal phenotype caused by large deletions. medRxiv. 2024. PMID:39802796

Djordjevic, D, Alawneh, I, Amburgey, K, Yuki, KE, Kyriakopoulou, LG, Navickiene, V et al.. A novel deep intronic variant in LAMA2 identified by RNA sequencing. Neuromuscul Disord. 2024.39 19-23 PMID:38691940

Xiao, L, Kang, S, Djordjevic, D, Gonorazky, H, Chiang, J, Ambreen, M et al.. Understanding caregiver experiences with disease-modifying therapies for spinal muscular atrophy: a qualitative study. Arch Dis Child. 2023.108 (11)929-934 PMID:37419673

Djordjevic, D, McFadyen, A, Anderson, JA. Ethical challenges and opportunities in the development and approval of novel therapeutics for rare diseases. J Med Access. 2023.7 27550834231177507 PMID:37323852

Djordjevic, D, Pinard, M, Gauthier, MS, Smith-Hicks, C, Hoffman, TL, Wolf, NI et al.. De novo variants in POLR3B cause ataxia, spasticity, and demyelinating neuropathy. Am J Hum Genet. 2022.109 (4)759-763 PMID:35395209

Djordjevic, D, Pinard, M, Gauthier, MS, Smith-Hicks, C, Hoffman, TL, Wolf, NI et al.. De novo variants in POLR3B cause ataxia, spasticity, and demyelinating neuropathy. Am J Hum Genet. 2021.108 (1)186-193 PMID:33417887

Djordjevic, D, Tsuchiya, E, Fitzpatrick, M, Sondheimer, N, Dowling, JJ. Utility of metabolic screening in neurological presentations of infancy. Ann Clin Transl Neurol. 2020.7 (7)1132-1140 PMID:32495504

Djordjevic, D, Fell, S, Baker, S. Effects of Self-Selected Exercise on Strength in Charcot-Marie-Tooth Disease Subtypes. Can J Neurol Sci. 2017.44 (5)572-576 PMID:28669366

See more on PubMed